Rachel Vaknin - 18 Jul 2022 Form 4 Insider Report for Microbot Medical Inc. (MBOT)

Role
Chief Financial Officer
Signature
/s/ Rachel Vaknin
Issuer symbol
MBOT
Transactions as of
18 Jul 2022
Net transactions value
$0
Form type
4
Filing time
20 Jul 2022, 16:30:17 UTC
Previous filing
15 Apr 2022
Next filing
09 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MBOT Stock Option (Right to Buy) Award $0 +10,000 $0.000000 10,000 18 Jul 2022 Common Stock, par value $0.01 per share 10,000 $4.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on January 18, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock.